AGAPE ATP CORPORATION Business Acquisition, Pro Forma Net Income (Loss)
AGAPE ATP CORPORATION (ATPC) reported Business Acquisition, Pro Forma Net Income (Loss) of $247.99 thousand for the 9-month period ending 2021-09-30, per its 10-Q/A filed 2022-07-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2022-07-05
- AGAPE ATP CORPORATION business acquisition, pro forma net income (loss) for the quarter ending 2021-09-30 was $183.29K, a 0.00% change year-over-year.
- AGAPE ATP CORPORATION business acquisition, pro forma net income (loss) for the quarter ending 2021-06-30 was $87.24K.
- AGAPE ATP CORPORATION business acquisition, pro forma net income (loss) for the quarter ending 2021-03-31 was -$22.54K.
- AGAPE ATP CORPORATION business acquisition, pro forma net income (loss) for the quarter ending 2020-12-31 was -$213.79K.
- AGAPE ATP CORPORATION business acquisition, pro forma net income (loss) for fiscal 2020 was $34.20K.
- AGAPE ATP CORPORATION business acquisition, pro forma net income (loss) for fiscal 2019 was -$1.78M.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month |
|---|---|---|---|---|
| 2021-09-30 | $183.29K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-07-05 | $270.53K derived: sum of 2 quarters · filed 2022-07-05 | $247.99K 10-Q/A · filed 2022-07-05 | $34.20K derived: sum of 4 quarters · filed 2022-07-05 |
| 2021-06-30 | $87.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $64.70K 10-Q · filed 2021-08-13 | -$149.09K derived: sum of 3 quarters · filed 2022-07-05 | $34.20K derived: sum of 4 quarters · filed 2022-07-05 |
| 2021-03-31 | -$22.54K 10-Q · filed 2021-05-17 | -$236.33K derived: sum of 2 quarters · filed 2022-07-05 | -$53.04K derived: sum of 3 quarters · filed 2022-07-05 | |
| 2020-12-31 | -$213.79K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-05 | -$30.50K derived: sum of 2 quarters · filed 2022-07-05 | $34.20K 10-K/A · filed 2022-07-05 | |
| 2020-09-30 | $183.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $247.99K 10-Q · filed 2020-11-16 | ||
| 2020-06-30 | $64.70K 10-Q · filed 2020-08-13 | |||
| 2019-12-31 | -$605.02K derived: 10-K 6 month − 10-Q 3 month · filed 2021-03-31 | -$731.49K 10-K · filed 2021-03-31 | -$1.57M derived: sum of 3 quarters · filed 2021-03-31 | -$1.78M 10-K · filed 2021-03-31 |
| 2019-09-30 | -$126.47K 10-Q · filed 2020-11-16 | -$963.54K derived: sum of 2 quarters · filed 2020-11-16 | -$1.17M 10-Q · filed 2020-11-16 | |
| 2019-06-30 | -$837.07K 10-Q · filed 2020-08-13 | -$1.04M 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |